The challenges of an HIV vaccine enterprise.
Rolf M
RM
Zinkernagel
D016915:AIDS Vaccines / Q000276:immunology; D001500:BCG Vaccine / Q000276:immunology; D014943:Global Health; D015658:HIV Infections / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D007111:Immunity, Cellular; D011634:Public Health; D014376:Tuberculosis / Q000276:immunology / Q000517:prevention & control
D016915:AIDS Vaccines; D001500:BCG Vaccine